Physician profile
Dixie Reid
NPI 1730198391
$1,509.86
in general payments reported to CMS, 2019-2025
22 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2024: $14.10 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.14 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $280.51 | 2025 | Interstim |
| Sumitomo Pharma America, INC. | $201.25 | 2025 | Orgovyx, Gemtesa |
| Daiichi Sankyo INC. | $124.72 | 2021 | |
| Novartis Pharmaceuticals Corporation | $91.12 | 2025 | |
| Astellas Pharma US INC | $81.42 | 2024-2025 | Xtandi, Vyloy |
| Janssen Biotech, INC. | $77.97 | 2025 | Erleada |
| Abc Home Medical Supply, INC. | $72.35 | 2025 | |
| Dendreon Pharmaceuticals LLC | $66.34 | 2025 | Provenge |
| Pfizer INC. | $66.04 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.74 | 2025 | |
| Merck Sharp & Dohme LLC | $49.87 | 2025 | Keytruda, Welireg |
| Accord Healthcare, INC. | $46.91 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $45.00 | 2025 | Lynparza |
| Urogen Pharma, INC. | $43.14 | 2025 | |
| Abbvie INC. | $36.95 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32.86 | 2025 | Nanoknife |
| Novo Nordisk INC | $29.25 | 2025 | Rivfloza |
| Ferring Pharmaceuticals INC. | $28.31 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $24.43 | 2025 | |
| Antares Pharma, INC. | $21.81 | 2025 | Xyosted |
| Innovation Technologies INC | $18.84 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $14.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixie Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.